Delivery Order SPE2DB20D3103-SPE2DB21FM7X6
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of a broad range of pharmaceutical products and medical supplies to support the U.S. Department of Defense and other federal healthcare programs. The contract, valued at $3,987.50, is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of medical products and supplies to support military healthcare programs and other federal agencies. The contract, valued at $1,217.58, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other federal healthcare programs. The contract, valued at $1,482.60, is a delivery order under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the Defense Logistics Agency (DLA) Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and other federal healthcare programs. The award, worth $5,370.52, is a delivery order placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical. This IDC serves...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and other federal healthcare programs. The contract, valued at up to $1,193.85, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00. This IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other federal healthcare programs. The $5,402.28 delivery order falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and related military healthcare programs. The $1,973.73 delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other federal agencies. The contract, valued at $10,053.13, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. This IDC, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a broad range of pharmaceutical products and medical supplies to support the U.S. Department of Defense's (DoD) healthcare programs. The $4,699.99 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical. This IDC serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the provision of a broad range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other federal healthcare programs. The contract, valued at $4,225.21, is a delivery order issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) worth up to $999,999,999.00, which runs through November 2026. This IDC...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FM7X6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other federal healthcare programs. The $2,400.80 contract was awarded by the Defense Logistics Agency (DLA) and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide essential pharmaceutical and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care items, to military treatment facilities and veterans' healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 3/15/21 |